Abstract PS5-01-23: Validation of the HER2DX Genomic Test in First-Line Advanced HER2-Positive Breast Cancer: Identifying Long-Term Responders to THPMarcin Kubeczko, F. Braso-Maritany, Jesús Soberino et al.|Clinical Cancer Research|2026Cited by 0
Abstract PS5-01-08: Development of the HER2DX Predictor of Brain Metastasis in Advanced HER2-Positive Breast Cancer Treated with First-Line THPRodrigo Sánchez-Bayona, M. Jarzab, Sandra Cobo et al.|Clinical Cancer Research|2026Cited by 0